Editing Austrianova is one organization that does services

that contains high tech, life sciences and biotech. It is accompanied with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science based business that focuses in the enclosure of living cells or bacteria in little pills for protection which is also recognized as cell encapsulation technology, isolation, storage and transportation. We were first created in the year 2007 and was recognised in Singapore's best exploration biotech hub, Biopolis that has international vision in supporting encapsulation services like micro encapsulation. 

There is a fast moving subject of interest in healthy maintenance and more specifically, in the subject of neutraceuticals which is the teaching and use of probiotic bacteria. So, probiotics encapsulation was built. The cell-in-a-box technology was formed by Austranova with the goal to defend, isolate, store and transfer living cells. This protective equipment can be used for many intentions and can be joined to probiotics, cosmetics and agriculture environmental protection and watching as well as developing the root of a authoritative investigation instrument. 

In healthcare, this knowledge aids facilitates protected attaching of cells or stem cells such as cell therapy, combining them alone from the immune system and giving long period manufacturing of therapeutic molecules in patients. In biotechnology, the cell-in-a-box creation guards cells in bioreactors and fermentors and at the same time, it make easier purification of bioproducts created from the cells and it shorten production price too.

A huge gauge cGMP facility for the making of biomedical grade encapsulated cell things was beforehand fruitfully established and right now, Austrianova is in the process of developing this ability in the whole of SE Asia. This means the use of cell-in-a-box was quite a achievement for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to allow minor quantities of chemotherapy to be used more successfully without the common incapacitating side effects. The encapsulated cell are placed, using supraselective catheterisation, into blood vessels that drives to the tumor where they locally convert a chemotherapeutic product to its tumor toxic product. 

Visit our website for additional information: <strong><b>[http://austrianova.com/ Encapsulation Technology]</b></strong>, <strong><b>[http://austrianova.com/ Micro Encapsulation]</b></strong>, <strong><b>[http://austrianova.com/ GMP Manufacturing]</b></strong>.